RETRACTED ARTICLE: Hypoxia-associated p38 mitogen-activated protein kinase-mediated androgen receptor activation and increased HIF-1α levels contribute to emergence of an aggressive phenotype in prostate cancer
Open Access
- 19 January 2009
- journal article
- research article
- Published by Springer Science and Business Media LLC in Oncogene
- Vol. 28 (9), 1248-1260
- https://doi.org/10.1038/onc.2008.476
Abstract
Androgen receptor (AR) signaling is involved in the development and progression of prostate cancer. Tumor microvasculature contributes to continual exposure of prostate cancer cells to hypoxia–reoxygenation, however, the role of hypoxia–reoxygenation in prostate cancer progression and modulation of AR signaling is not understood. In this study, we evaluated the effects of hypoxia–reoxygenation in LNCaP cells, a line of hormone responsive human prostate cancer cells. Our results demonstrate that hypoxia–reoxygenation resulted in increased survival, higher clonogenicity and enhanced invasiveness of these cells. Moreover, hypoxia–reoxygenation was associated with an increased AR activity independent of androgens as well as increased hypoxia inducible factor (HIF-1α) levels and activity. We also observed that the activation of p38 mitogen-activated protein (MAP) kinase pathway was an early response to hypoxia, and inhibition of p38 MAP kinase pathway by variety of approaches abolished hypoxia–reoxygenation induced increased AR activity as well as increased survival, clonogenicity and invasiveness. These results demonstrate a critical role for hypoxia-induced p38 MAP kinase pathway in androgen-independent AR activation in prostate cancer cells, and suggest that hypoxia–reoxygenation may select for aggressive androgen-independent prostate cancer phenotype.Keywords
This publication has 62 references indexed in Scilit:
- Mutations in gidB Confer Low-Level Streptomycin Resistance in Mycobacterium tuberculosisAntimicrobial Agents and Chemotherapy, 2011
- Feasibility, diagnostic accuracy, and effectiveness of decentralised use of the Xpert MTB/RIF test for diagnosis of tuberculosis and multidrug resistance: a multicentre implementation studyThe Lancet, 2011
- Human T cell epitopes of Mycobacterium tuberculosis are evolutionarily hyperconservedNature Genetics, 2010
- Tuberculosis Drug Resistance Mutation DatabasePLoS Medicine, 2009
- Genetic evaluation of relationship between mutations in rpoB and resistance of Mycobacterium tuberculosis to rifampinBMC Microbiology, 2009
- High Functional Diversity in Mycobacterium tuberculosis Driven by Genetic Drift and Human DemographyPLoS Biology, 2008
- Evaluation and Strategy for Use of MIRU-VNTRplus, a Multifunctional Database for Online Analysis of Genotyping Data and Phylogenetic Identification ofMycobacterium tuberculosisComplex IsolatesJournal of Clinical Microbiology, 2008
- Identification of Mutations Related to Streptomycin Resistance in Clinical Isolates of Mycobacterium tuberculosis and Possible Involvement of Efflux MechanismAntimicrobial Agents and Chemotherapy, 2008
- Evaluation of the GenoType MTBDRplus Assay for Rifampin and Isoniazid Susceptibility Testing of Mycobacterium tuberculosis Strains and Clinical SpecimensJournal of Clinical Microbiology, 2007
- Role of protein kinase Cδ in transmitting hypoxia signal to HSF and HIF‐1Journal of Cellular Physiology, 2001